Nothing Special   »   [go: up one dir, main page]

CN110396068A - 4-O-alkoxyaryl-1,2,3-triazole derivatives, synthetic method and application - Google Patents

4-O-alkoxyaryl-1,2,3-triazole derivatives, synthetic method and application Download PDF

Info

Publication number
CN110396068A
CN110396068A CN201910661275.2A CN201910661275A CN110396068A CN 110396068 A CN110396068 A CN 110396068A CN 201910661275 A CN201910661275 A CN 201910661275A CN 110396068 A CN110396068 A CN 110396068A
Authority
CN
China
Prior art keywords
triazole
alkoxyaryl
triazole derivatives
ome
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910661275.2A
Other languages
Chinese (zh)
Other versions
CN110396068B (en
Inventor
江玉波
董鲜
杨健华
肖铁波
刘耀文
任永生
陈俊宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University of Science and Technology
Original Assignee
Kunming University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University of Science and Technology filed Critical Kunming University of Science and Technology
Priority to CN201910661275.2A priority Critical patent/CN110396068B/en
Publication of CN110396068A publication Critical patent/CN110396068A/en
Application granted granted Critical
Publication of CN110396068B publication Critical patent/CN110396068B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开结构式如式Ⅰ或式Ⅱ所示的4‑邻烷氧芳基‑1,2,3‑三唑衍生物:,其中R1选自H、Me、OMe、OH、CH2OH、F、Cl、Br;R2选自H、Me、OMe、F、Cl、Br;R3选自H、Me、OMe、OEt、 n PrO、F、Cl、Br;R4选自Me、Et、 n Pr、 i Pr、Cy;本发明以1,4‑二取代‑1,2,3‑三氮唑为原料,在过渡金属催化作用下使4号位芳基邻位碳‑氢键直接转变为烷氧基,选择性合成4‑邻烷氧芳基‑1,2,3‑三唑衍生物;本发明合成的化合物同时含有1,2,3‑三唑环及烷氧基官能团,对三七根腐病致病菌具有很好的抑制效果。The present invention discloses a 4-o-alkoxyaryl-1,2,3-triazole derivative with a structural formula such as formula I or formula II: , wherein R 1 is selected from H, Me, OMe, OH, CH 2 OH, F, Cl, Br; R 2 is selected from H, Me, OMe, F, Cl, Br; R 3 is selected from H, Me, OMe, OEt, n PrO, F, Cl, Br; R 4 is selected from Me, Et, n Pr, i Pr, Cy; the present invention takes 1,4-disubstituted-1,2,3-triazole as raw material, in Under the action of transition metal catalysis, the ortho-position carbon-hydrogen bond of the 4th aryl group is directly converted into an alkoxy group, and the 4-ortho-alkoxy aryl-1,2,3-triazole derivative is selectively synthesized; The compound contains 1,2,3-triazole ring and alkoxy functional group at the same time, and has a good inhibitory effect on the pathogenic bacteria of Panax notoginseng root rot.

Description

4-邻烷氧芳基-1,2,3-三唑衍生物及合成方法和应用4-O-alkoxyaryl-1,2,3-triazole derivatives, synthetic method and application

技术领域technical field

本发明涉及一种4-邻烷氧芳基-1,2,3-三唑衍生物及合成方法和应用,属于农药及有机合成技术领域。The invention relates to a 4-o-alkoxyaryl-1,2,3-triazole derivative, a synthesis method and application, and belongs to the technical field of pesticides and organic synthesis.

背景技术Background technique

三氮唑类化合物在医药、农药及材料等领域已广泛应用,一直以来备受化学家们的重视。尤其在Sharpless发现有机叠氮与末端炔的点击反应之后,1,2,3-三氮唑类化合物的该类化合物的设计、合成及应用发展尤为迅速,并已广泛应用于抗菌、抗流感、抗癫痫、免疫及治疗肿瘤、关节炎、软骨病等方面(Kantheti S., Narayan R., Raju K. V. S. N. RSC Adv., 2015, 5, 3687; Schulze B., Schubert U. S. Chem. Soc. Rev., 2014,43, 2522.)。三七作为名贵栽培药用植物,随着社会需求量的不断增加,三七种植面积不断扩大,其病害问题日益严重,已成为三七生产的主要障碍;由于三七的经济部位是根系,所以根部腐烂成为直接影响三七产量、品质及商品价值的最严重病害,因而三七根腐病的防治工作以及新型抗菌剂的研发尤为重要。Triazole compounds have been widely used in the fields of medicine, pesticides and materials, and have always been valued by chemists. Especially after Sharpless discovered the click reaction between organic azides and terminal alkynes, the design, synthesis and application of 1,2,3-triazole compounds have developed rapidly, and have been widely used in antibacterial, anti-influenza, Anti-epileptic, immune and treatment of tumor, arthritis, osteomalacia, etc. (Kantheti S., Narayan R., Raju K. V. S. N. RSC Adv., 2015,5, 3687; Schulze B., Schubert U. S.Chem. Soc. Rev., 2014,43, 2522.). As a valuable cultivated medicinal plant, with the continuous increase of social demand, the planting area of Panax notoginseng continues to expand, and its disease problem is becoming more and more serious, which has become the main obstacle to the production of Panax notoginseng; Root rot has become the most serious disease that directly affects the yield, quality and commodity value of Panax notoginseng. Therefore, the prevention and control of Panax notoginseng root rot and the research and development of new antibacterial agents are particularly important.

功能化三氮唑的来源主要有以下几类途径:方法一是通过炔与叠氮类化合物发生环加成反应,在亚铜催化下可选择性得到1,4-二取代-1,2,3-三氮唑衍生物,而在钌或季胺碱催化下得则到1,5-二取代-1,2,3-三氮唑衍生物(Luciani, L., et al. Green Chem.,2018, 20, 183; Liu, P., et al. J. Org. Chem., 2018, 83, 5092.);方法二是使用有机叠氮化合物和烯烃作为底物,发生有机催化环加成反应(Rohilla, S., et al. Eur. J. Org. Chem., 2016, 847; Li, W., et al. RSC Adv., 2015, 5, 88816.);方法三是直接对1,2,3-三氮唑衍生物进行修饰(Ma, X.; et al. Synthesis, 2018, 50, 2567; ZhaoF., et al. Org. Chem. Front., 2017, 4, 1112; Zhao S., et al. Org. Lett.,2015, 17, 2828.),包括烯基化、酰氧基化、烷氧基化、芳基化等过程,得到功能化1,2,3-三氮唑结构。The sources of functionalized triazoles are mainly as follows: Method one is through the cycloaddition reaction between alkynes and azides, which can selectively obtain 1,4-disubstituted-1,2, 3-triazole derivatives, and 1,5-disubstituted-1,2,3-triazole derivatives obtained under the catalysis of ruthenium or quaternary amine bases (Luciani, L., et al. Green Chem . , 2018, 20 , 183; Liu, P., et al. J. Org. Chem ., 2018, 83 , 5092.); The second method is to use organic azides and alkenes as substrates to undergo organocatalytic cycloaddition Reaction (Rohilla, S., et al. Eur. J. Org. Chem., 2016, 847; Li, W., et al. RSC Adv. , 2015, 5 , 88816.); Method 3 is directly to 1, 2,3-triazole derivatives were modified (Ma, X.; et al. Synthesis , 2018, 50 , 2567; ZhaoF., et al. Org. Chem. Front ., 2017, 4 , 1112; Zhao S. , et al. Org. Lett ., 2015, 17 , 2828.), including alkenylation, acyloxylation, alkoxylation, arylation and other processes to obtain functionalized 1,2,3-triazoles structure.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种4-邻烷氧芳基 -1,2,3-三唑衍生物,其化学结构式如下:The object of the present invention is to provide a kind of 4-o-alkoxy aryl-1,2,3-triazole derivative, and its chemical structural formula is as follows:

,

其中R1选自H、Me、OMe、OH、CH2OH、F、Cl、Br;R2选自H、Me、OMe、F、Cl、Br;R3选自H、Me、OMe、OEt、 n PrO、F、Cl、Br;R4选自Me、Et、 n Pr、 i Pr、Cy。Wherein R 1 is selected from H, Me, OMe, OH, CH 2 OH, F, Cl, Br; R 2 is selected from H, Me, OMe, F, Cl, Br; R 3 is selected from H, Me, OMe, OEt , n PrO, F, Cl, Br; R 4 is selected from Me, Et, n Pr, i Pr, Cy.

上述4-邻烷氧芳基-1,2,3-三唑衍生物的合成方法如下:The synthetic method of above-mentioned 4-o-alkoxyaryl-1,2,3-triazole derivatives is as follows:

(1)按1,4-二取代-1,2,3-三氮唑、催化剂、氧化剂、溶剂的摩尔比为1:(0.01~0.3):(2~7):(20~80)的比例,依次将1,4-二取代-1,2,3-三氮唑、催化剂、氧化剂、溶剂加入到反应器中,在70℃-150℃下反应6~24小时;(1) According to the molar ratio of 1,4-disubstituted-1,2,3-triazole, catalyst, oxidant and solvent, it is 1:(0.01~0.3):(2~7):(20~80) ratio, add 1,4-disubstituted-1,2,3-triazole, catalyst, oxidant and solvent into the reactor in turn, and react at 70℃-150℃ for 6-24 hours;

(2)反应产物水稀释后用乙酸乙酯多次萃取,收集合并萃取液,洗涤干燥后,减压蒸馏得粗产品,再分离提纯,即得4-邻烷氧芳基-1,2,3-三唑衍生物。(2) After the reaction product is diluted with water, it is extracted several times with ethyl acetate, and the combined extracts are collected, washed and dried, and then distilled under reduced pressure to obtain the crude product, which is then separated and purified to obtain 4-o-alkoxyaryl-1,2, 3-triazole derivatives.

所述催化剂为醋酸钯、二氯化钯、三(二亚苄基丙酮)二钯、双二亚苄基丙酮钯、四三苯基膦钯中的一种。The catalyst is one of palladium acetate, palladium dichloride, tris(dibenzylideneacetone)dipalladium, bisdibenzylideneacetone palladium and tetrakistriphenylphosphine palladium.

所述氧化剂为过硫酸钾、过硫酸铵、过硫酸钠、过硫酸氢钾、过氧化二叔丁醇中的一种;The oxidant is one of potassium persulfate, ammonium persulfate, sodium persulfate, potassium hydrogen persulfate and di-tert-butanol peroxide;

本发明的有益效果为:以易得的1,4-二取代-1,2,3-三氮唑为起始原料,将4号位芳基邻位C-H键直接转变为烷氧基,从而选择性地获得4-邻烷氧芳基-1,2,3-三唑衍生物,所合成的化合物同时含有1,2,3-三唑环及烷氧基官能团结构单元,对三七根腐病病原菌具有很好的抑制效果,具有一定的应用前景,亦可为功能分子的合成与修饰提供一种新方法。The beneficial effects of the invention are as follows: using readily available 1,4-disubstituted-1,2,3-triazole as the starting material, the ortho-position C-H bond of the aryl group at the 4th position is directly converted into an alkoxy group, thereby Selectively obtain 4-o-alkoxyaryl-1,2,3-triazole derivatives. The synthesized compounds contain both 1,2,3-triazole ring and alkoxy functional group structural units. The rot pathogen has a good inhibitory effect, has a certain application prospect, and can also provide a new method for the synthesis and modification of functional molecules.

具体实施方式Detailed ways

下面结合实施例对本发明作进一步详细说明,但本发明保护范围不局限于所述内容。The present invention will be described in further detail below with reference to the examples, but the protection scope of the present invention is not limited to the content.

实施例1:4-(2,6-二甲氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑(2a)的合成,具体包括以下步骤:Example 1: Synthesis of 4-(2,6-dimethoxyphenyl)-1-(p-tolyl)-1H- 1,2,3 -triazole (2a), specifically comprising the following steps:

(1)按1-对甲苯基-4-苯基-1,2,3-三氮唑(1a)、醋酸钯、过硫酸钾、甲醇溶剂的摩尔比为1:0.05:7:80的比例,依次将1mmol 1-对甲苯基-4-苯基-1,2,3-三氮唑、0.05mmol醋酸钯、7mmol过硫酸钾、80mmol甲醇溶剂加入到反应器中,在150℃反应24h;(1) The molar ratio of 1-p-tolyl-4-phenyl-1,2,3-triazole (1a), palladium acetate, potassium persulfate and methanol solvent is 1:0.05:7:80 , 1mmol of 1-p-tolyl-4-phenyl-1,2,3-triazole, 0.05mmol of palladium acetate, 7mmol of potassium persulfate, and 80mmol of methanol solvent were added to the reactor in turn, and the reaction was carried out at 150°C for 24h;

(2)所得反应产物用40mL水稀释,再用120mL乙酸乙酯萃取反应产物3次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再用乙酸乙酯-石油醚混合液(乙酸乙酯和石油醚的体积比1:6)为淋洗液进行柱层析(400目硅胶)提纯即得245mg产品4-(2,6-二甲氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑2a,收率为83%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted with 120 mL of ethyl acetate for 3 times. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then used ethyl acetate-petroleum ether. The mixed solution (volume ratio of ethyl acetate and petroleum ether: 1:6) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 245 mg of product 4-(2,6-dimethoxyphenyl)-1 -(p- Tolyl )-1H-1,2,3-triazole 2a, the yield is 83%, the reaction equation is as follows:

;

产物核磁共振谱表征数据如下:1H NMR (400 MHz, CDCl3) δ = 8.07 (s, 1H), 7.67(d, J = 8.4 Hz, 2H), 7.30 (dd, J = 8.3, 2.0 Hz, 3H), 6.66 (d, J = 8.4 Hz,2H), 3.82 (s, 6H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 158.4, 140.3,138.2, 134.9, 129.9, 129.8, 122.2, 120.3, 108.4, 104.1, 55.9, 20.9。The NMR spectral characterization data of the product are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ = 8.07 (s, 1H), 7.67(d, J = 8.4 Hz, 2H), 7.30 (dd, J = 8.3, 2.0 Hz, 3H), 6.66 (d, J = 8.4 Hz, 2H), 3.82 (s, 6H), 2.41 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ = 158.4, 140.3, 138.2, 134.9, 129.9 , 129.8, 122.2, 120.3, 108.4, 104.1, 55.9, 20.9.

实施例2: 1-苯基-4-(2,6-二甲氧苯基)-1H-1,2,3-三唑(2b)的合成,具体包括以下步骤:Example 2: Synthesis of 1-phenyl-4-(2,6-dimethoxyphenyl)-1H- 1,2,3 -triazole (2b), specifically comprising the following steps:

(1)按1-苯基-4-苯基-1H-1,2,3-三唑(1b)、氯化钯、过硫酸铵、甲醇溶剂的摩尔比为1:0.01:6:70的比例,依次将1mmol 1-苯基-4-苯基-1H-1,2,3-三唑、0.01mmol氯化钯、6mmol过硫酸铵、70mmol甲醇溶剂加入到反应器中,在140℃反应22h;(1) The molar ratio of 1-phenyl-4-phenyl-1 H -1,2,3-triazole (1b), palladium chloride, ammonium persulfate and methanol solvent is 1:0.01:6:70 The ratio of 1 mmol 1-phenyl-4-phenyl-1 H -1,2,3-triazole, 0.01 mmol palladium chloride, 6 mmol ammonium persulfate, 70 mmol methanol solvent was added to the reactor in turn, and at 140 ℃ reaction 22h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯160mL萃取反应产物4次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:2)为淋洗液进行柱层析(400目硅胶)提纯即得225mg产品1-苯基-4-(2,6-二甲氧苯基)-1H-1,2,3-三唑2b,收率为80%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted 4 times with 160 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:2) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 225 mg of product 1-phenyl-4-(2,6-dimethoxyphenyl)-1 H -1 , 2,3-triazole 2b, the yield is 80%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.12 (s, 1H), 7.81(dd, J = 8.5, 1.0 Hz, 2H), 7.56 – 7.49 (m, 2H), 7.42 (dd, J = 10.7, 4.2 Hz,1H), 7.33 (t, J = 8.4 Hz, 1H), 6.68 (d, J = 8.4 Hz, 2H), 3.84 (s, 6H). 13C NMR(150 MHz, CDCl3) δ = 158.4, 140.6, 137.3, 129.9, 129.6, 128.3, 122.3, 120.5,108.3, 104.1, 56.0。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.12 (s, 1H), 7.81 (dd, J = 8.5, 1.0 Hz, 2H), 7.56 – 7.49 (m, 2H), 7.42 (dd, J = 10.7, 4.2 Hz, 1H), 7.33 (t, J = 8.4 Hz, 1H), 6.68 (d, J = 8.4 Hz, 2H), 3.84 (s, 6H). 13 C NMR(150 MHz, CDCl 3 ) δ = 158.4, 140.6, 137.3, 129.9, 129.6, 128.3, 122.3, 120.5, 108.3, 104.1, 56.0.

实施例3:1-邻甲基苯基-4-(2,6-二甲氧苯基)-1H-1,2,3-三唑(2c)的合成,具体包括以下步骤:Example 3: Synthesis of 1-o-methylphenyl-4-(2,6-dimethoxyphenyl)-1H- 1,2,3 -triazole (2c), specifically comprising the following steps:

(1)按1-邻甲基苯基-4-苯基-1H-1,2,3-三唑(1c)、三(二亚苄基丙酮)二钯、过硫酸钠、甲醇溶剂的摩尔比为1: 0.10:4:40的比例,依次将1mmol 1-邻甲基苯基-4-苯基-1H-1,2,3-三唑、0.10mmol三(二亚苄基丙酮)二钯、4mmol过硫酸钠、40mmol甲醇加入到反应器中,在80℃反应10h;(1) According to 1-o-methylphenyl-4-phenyl- 1H -1,2,3-triazole (1c), tris(dibenzylideneacetone)dipalladium, sodium persulfate, methanol solvent The molar ratio is the ratio of 1: 0.10: 4: 40, and 1 mmol 1-o-methylphenyl-4-phenyl-1 H -1,2,3-triazole, 0.10 mmol tris(dibenzylideneacetone) ) Dipalladium, 4mmol sodium persulfate and 40mmol methanol were added to the reactor, and the reaction was carried out at 80°C for 10h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯160mL萃取反应产物4次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:2)为淋洗液进行柱层析(400目硅胶)提纯即得233mg产品1-邻甲基苯基-4-(2,6-二甲氧苯基)-1H-1,2,3-三唑2c,收率为79%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted 4 times with 160 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:2) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 233 mg of the product 1-o-methylphenyl-4-(2,6-dimethoxyphenyl)-1 H -1,2,3-triazole 2c, the yield is 79%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (400 MHz, CDCl3) δ = 7.92 (s, 1H), 7.46(d, J = 7.6 Hz, 1H), 7.43 – 7.29 (m, 5H), 6.68 (d, J = 8.4 Hz, 2H), 3.84 (s,6H), 2.30 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 158.4, 139.7, 136.8, 133.6,131.4, 129.8, 129.5, 126.8, 126.1, 126.0, 108.5, 104.3, 56.1, 18.0。The NMR spectral characterization data of the products are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ = 7.92 (s, 1H), 7.46(d, J = 7.6 Hz, 1H), 7.43 – 7.29 (m, 5H), 6.68 ( d, J = 8.4 Hz, 2H), 3.84 (s, 6H), 2.30 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ = 158.4, 139.7, 136.8, 133.6, 131.4, 129.8, 129.5, 126.8, 126.1, 126.0, 108.5, 104.3, 56.1, 18.0.

实施例4:1-苯基-4-(2,6-二甲氧基-4-甲基苯基)-1H-1,2,3-三唑(2d)合成,具体包括以下步骤:Example 4: Synthesis of 1-phenyl-4-(2,6-dimethoxy-4-methylphenyl)-1H- 1,2,3 -triazole (2d), which specifically includes the following steps:

(1)按1-苯基-4-对甲苯基-1H-1,2,3-三唑(1d)、双二亚苄基丙酮钯、过硫酸氢钾、甲醇的摩尔比为1:0.20:5:50的比例,依次将1mmol 1-苯基-4-对甲苯基-1H-1,2,3-三唑、0.20mmol双二亚苄基丙酮钯、5mmol过硫酸氢钾、50mmol甲醇加入到反应器中,在70℃反应8h;(1) According to the molar ratio of 1-phenyl-4-p-tolyl- 1H -1,2,3-triazole (1d), bis-dibenzylideneacetone palladium, potassium hydrogen persulfate and methanol is 1: In a ratio of 0.20:5:50, 1 mmol 1-phenyl-4-p-tolyl-1 H -1,2,3-triazole, 0.20 mmol bis-dibenzylidene acetone palladium, 5 mmol potassium hydrogen persulfate, 50mmol methanol was added to the reactor and reacted at 70°C for 8h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯120mL萃取反应产物3次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:4)为淋洗液进行柱层析(400目硅胶)提纯即得230mg产品1-苯基-4-(2,6-二甲氧基-4-甲基苯基)-1H-1,2,3-三唑2d,收率为77%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted three times with 120 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:4) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 230 mg of the product 1-phenyl-4-(2,6-dimethoxy-4-methylphenyl) )-1H- 1,2,3 -triazole 2d, the yield is 77%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.08 (s, 1H), 7.99(t, J = 1.9 Hz, 1H), 7.77 (dd, J = 8.1, 1.2 Hz, 1H), 7.54 (dd, J = 8.0, 0.8Hz, 1H), 7.39 (t, J = 8.1 Hz, 1H), 6.50 (s, 2H), 3.82 (s, 6H), 2.41 (s, 3H).13C NMR (150 MHz, CDCl3) δ = 158.1, 141.1, 140.5, 138.2, 131.2, 130.9, 123.4,123.0, 122.0, 118.9, 105.1, 105.0, 55.9, 22.2。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.08 (s, 1H), 7.99(t, J = 1.9 Hz, 1H), 7.77 (dd, J = 8.1, 1.2 Hz, 1H), 7.54 (dd, J = 8.0, 0.8Hz, 1H), 7.39 (t, J = 8.1 Hz, 1H), 6.50 (s, 2H), 3.82 (s, 6H), 2.41 (s, 3H). 13 C NMR (150 MHz, CDCl 3 ) δ = 158.1, 141.1, 140.5, 138.2, 131.2, 130.9, 123.4, 123.0, 122.0, 118.9, 105.1, 105.0, 55.9, 22.2.

实施例5:1-对甲苯基-4-(2-甲氧基-6-溴苯基)-1H-1,2,3-三唑(2e)合成,具体包括以下步骤:Example 5: Synthesis of 1-p-tolyl-4-(2-methoxy-6-bromophenyl)-1 H -1,2,3-triazole (2e), including the following steps:

(1)按1-对甲苯基-4-邻溴苯基-1H-1,2,3-三唑(1e)、四三苯基膦钯、过氧化二叔丁醇、甲醇的摩尔比为1:0.25:6:70的比例,依次将1mmol 1-对甲苯基-4-邻溴苯基-1H-1,2,3-三唑、0.25mmol四三苯基膦钯、6mmol过氧化二叔丁醇、70mmol甲醇加入到反应器中,在100℃反应6小时;(1) According to the molar ratio of 1-p-tolyl-4-o-bromophenyl-1 H -1,2,3-triazole (1e), tetrakistriphenylphosphine palladium, di-tert-butanol peroxide and methanol In a ratio of 1:0.25:6:70, 1 mmol of 1-p-tolyl-4-o-bromophenyl-1 H -1,2,3-triazole, 0.25 mmol of tetrakistriphenylphosphine palladium, 6 mmol of Oxidized di-tert-butanol and 70 mmol of methanol were added to the reactor and reacted at 100°C for 6 hours;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯120mL萃取步骤反应产物4次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:4)为淋洗液进行柱层析(400目硅胶)提纯即得248mg产品1-对甲苯基-4-(2-甲氧基-6-溴苯基)-1H-1,2,3-三唑2e,收率为72%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted 4 times with 120 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then extracted with ethyl acetate-petroleum The ether mixture (volume ratio 1:4) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 248 mg of the product 1-p-tolyl-4-(2-methoxy-6-bromophenyl)- 1 H -1,2,3-triazole 2e, the yield is 72%, the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (400 MHz, CDCl3) δ = 8.05 (s, 1H), 7.67(d, J = 8.4 Hz, 2H), 7.32 – 7.24 (m, 3H), 7.10 (dd, J = 8.1, 0.8 Hz, 1H),6.88 (d, J = 8.3 Hz, 1H), 3.77 (s, 3H), 2.40 (s, 3H). 13C NMR (100 MHz, CDCl3)δ = 158.6, 140.9, 138.4, 134.9, 134.6, 130.0, 129.9, 122.1, 121.8, 120.1,118.8, 109.3, 55.9, 20.9。The NMR spectral characterization data of the product are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ = 8.05 (s, 1H), 7.67(d, J = 8.4 Hz, 2H), 7.32 – 7.24 (m, 3H), 7.10 ( dd, J = 8.1, 0.8 Hz, 1H), 6.88 (d, J = 8.3 Hz, 1H), 3.77 (s, 3H), 2.40 (s, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ = 158.6, 140.9, 138.4, 134.9, 134.6, 130.0, 129.9, 122.1, 121.8, 120.1, 118.8, 109.3, 55.9, 20.9.

实施例6:1-间甲苯甲基-4-邻异丁氧苯基-1H-1,2,3-三唑(2f)合成,具体包括以下步骤:Embodiment 6: Synthesis of 1-m-tolylmethyl-4-o-isobutoxyphenyl-1 H -1,2,3-triazole (2f), which specifically includes the following steps:

(1)按1-间甲苯甲基-4-苯基-1H-1,2,3-三唑(1f)、氯化钯、过硫酸钾、异丁醇的摩尔比为1:0.30:3:40的比例,依次将1mmol 苯甲基-4-苯基-1H-1,2,3-三唑、0.30mmol氯化钯、3mmol过硫酸钾、40mmol异丁醇加入到反应器中,在90℃反应12h;(1) According to the molar ratio of 1-m-tolylmethyl-4-phenyl-1 H -1,2,3-triazole (1f), palladium chloride, potassium persulfate and isobutanol, it is 1:0.30: In the ratio of 3:40, 1mmol of benzyl-4-phenyl- 1H -1,2,3-triazole, 0.30mmol of palladium chloride, 3mmol of potassium persulfate and 40mmol of isobutanol were successively added to the reactor , react at 90°C for 12h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯120mL萃取反应产物3次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:6)为淋洗液进行柱层析(400目硅胶)提纯即得268mg产品1-间甲苯甲基-4-异丁氧苯基-1H-1,2,3-三唑2f,收率为83%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted three times with 120 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:6) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 268 mg of the product 1-m-tolylmethyl-4-isobutoxyphenyl-1 H -1,2,3 -triazole 2f, the yield is 83%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.33 (dd, J = 7.7,1.6 Hz, 1H), 7.94 (s, 1H), 7.28 – 7.24 (m, 2H), 7.16 (d, J = 7.6 Hz, 1H),7.12 (d, J = 5.7 Hz, 2H), 7.05 (t, J = 7.5 Hz, 1H), 6.90 (d, J = 8.3 Hz, 1H),5.53 (s, 2H), 3.78 (d, J = 6.3 Hz, 2H), 2.33 (s, 3H), 2.01 (dp, J = 13.2, 6.6Hz, 1H), 0.92 (d, J = 6.8 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ = 155.1, 143.5,138.9, 134.6, 129.3, 128.9, 128.8, 127.6, 125.3, 122.9, 120.7, 119.3, 111.4,75.6, 54.0, 28.3, 21.3, 19.4。The NMR spectral characterization data of the products are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.33 (dd, J = 7.7, 1.6 Hz, 1H), 7.94 (s, 1H), 7.28 – 7.24 (m, 2H), 7.16 (d, J = 7.6 Hz, 1H), 7.12 (d, J = 5.7 Hz, 2H), 7.05 (t, J = 7.5 Hz, 1H), 6.90 (d, J = 8.3 Hz, 1H), 5.53 ( s, 2H), 3.78 (d, J = 6.3 Hz, 2H), 2.33 (s, 3H), 2.01 (dp, J = 13.2, 6.6Hz, 1H), 0.92 (d, J = 6.8 Hz, 6H). 13 C NMR (150 MHz, CDCl 3 ) δ = 155.1, 143.5, 138.9, 134.6, 129.3, 128.9, 128.8, 127.6, 125.3, 122.9, 120.7, 119.3, 111.4, 75.6, 54.0, 19.28.3

实施例7:4-(2,6-二乙氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑(2g)合成,具体包括以下步骤:Example 7: Synthesis of 4-(2,6-diethoxyphenyl)-1-(p-tolyl)-1H- 1,2,3 -triazole (2g), specifically including the following steps:

(1)按4-苯基-1-(对甲苯基)-1H-1,2,3-三唑(1a)、三二亚苄基丙酮二钯、过硫酸氢钾、乙醇的摩尔比为1:0.25:2:30的比例,依次将1mmol 4-苯基-1-(对甲苯基)-1H-1,2,3-三唑、0.25mmol三二亚苄基丙酮二钯、2mmol过硫酸氢钾、30mmol乙醇加入到反应器中,在100℃反应14h;(1) According to the molar ratio of 4-phenyl-1-(p-tolyl)-1 H -1,2,3-triazole (1a), tridibenzylideneacetone dipalladium, potassium hydrogen persulfate and ethanol In a ratio of 1:0.25:2:30, 1 mmol 4-phenyl-1-(p-tolyl)-1 H -1,2,3-triazole, 0.25 mmol tridibenzylideneacetone dipalladium, 2 mmol potassium hydrogen persulfate and 30 mmol ethanol were added to the reactor, and the reaction was carried out at 100 °C for 14 h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯150mL萃取反应产物4次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:4)为淋洗液进行柱层析(400目硅胶)提纯即得262mg产品4-(2,6-二乙氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑2g,收率为81%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted 4 times with 150 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:4) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 262 mg of product 4-(2,6-diethoxyphenyl)-1-(p-tolyl)- 1 H -1,2,3-triazole 2g, the yield is 81%, the reaction equation is as follows:

产物核磁共振谱表征数据如下: 1H NMR (600 MHz, CDCl3) δ = 8.10 (s, 1H),7.67 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 7.26 (dd, J = 10.3, 6.4Hz, 1H), 6.64 (d, J = 8.4 Hz, 2H), 4.07 (q, J = 7.0 Hz, 4H), 2.42 (s, 3H),1.35 (t, J = 7.0 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ = 157.8, 140.6, 138.2,135.0, 130.1, 129.6, 122.2, 120.2, 109.3, 105.5, 64.5, 21.0, 14.7。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.10 (s, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H) , 7.26 (dd, J = 10.3, 6.4Hz, 1H), 6.64 (d, J = 8.4 Hz, 2H), 4.07 (q, J = 7.0 Hz, 4H), 2.42 (s, 3H), 1.35 (t, J = 7.0 Hz, 6H). 13 C NMR (150 MHz, CDCl 3 ) δ = 157.8, 140.6, 138.2, 135.0, 130.1, 129.6, 122.2, 120.2, 109.3, 105.5, 64.5, 21.0, 14.7.

实施例8:4-(2,6-二丙)-1-(对甲苯基)-1H-1,2,3-三唑(2h)合成,具体包括以下步骤:Example 8: Synthesis of 4-(2,6-dipropyl)-1-(p-tolyl)-1H- 1,2,3 -triazole (2h), specifically including the following steps:

(1)按4-苯基-1-(对甲苯基)-1H-1,2,3-三唑(1a)、醋酸钯、过硫酸铵、正丙醇的摩尔比为1:0.20:3:40的比例,依次将1mmol 4-苯基-1-(对甲苯基)-1H-1,2,3-三唑、0.20mmol醋酸钯、3mmol过硫酸铵、40mmol正丙醇加入到反应器中,在110℃反应16h;(1) The molar ratio of 4-phenyl-1-(p-tolyl)-1H- 1,2,3 -triazole (1a), palladium acetate, ammonium persulfate and n-propanol is 1:0.20: In a ratio of 3:40, 1 mmol 4-phenyl-1-(p-tolyl)-1 H -1,2,3-triazole, 0.20 mmol palladium acetate, 3 mmol ammonium persulfate and 40 mmol n-propanol were added to the mixture in turn. In the reactor, the reaction was carried out at 110°C for 16h;

(2)所得反应产物用40mL水稀释,再以乙酸乙酯100mL萃取反应产物3次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:3)为淋洗液进行柱层析(400目硅胶)提纯即得278mg产品4-(2,6-二丙)-1-(对甲苯基)-1H-1,2,3-三唑2h,收率为79%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted three times with 100 mL of ethyl acetate. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then extracted with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:3) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 278 mg of the product 4-(2,6-dipropyl)-1-(p-tolyl)-1 H -1 , 2,3-triazole 2h, the yield is 79%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.08 (s, 1H), 7.67(d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 2.6 Hz, 1H), 6.64(d, J = 8.4 Hz, 2H), 3.96 (t, J = 6.5 Hz, 4H), 2.43 (s, 3H), 1.79 – 1.72 (m,4H), 0.95 (t, J = 7.4 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ = 158.0, 140.7,138.2, 135.1, 130.1, 129.7, 122.1, 120.3, 109.3, 105.4, 70.5, 22.5, 21.1,10.5。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.08 (s, 1H), 7.67(d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H) , 7.26 (d, J = 2.6 Hz, 1H), 6.64(d, J = 8.4 Hz, 2H), 3.96 (t, J = 6.5 Hz, 4H), 2.43 (s, 3H), 1.79 – 1.72 (m, 4H), 0.95 (t, J = 7.4 Hz, 6H). 13 C NMR (150 MHz, CDCl 3 ) δ = 158.0, 140.7, 138.2, 135.1, 130.1, 129.7, 122.1, 120.3, 109.3, 105.4, 70.5, 22.5 , 21.1, 10.5.

实施例9:4-(2-异丙氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑(2i)合成,具体包括以下步骤:Example 9: Synthesis of 4-(2-isopropoxyphenyl)-1-(p-tolyl)-1H- 1,2,3 -triazole (2i), including the following steps:

(1)按4-苯基-1-(对甲苯基)-1H-1,2,3-三唑(1a)、四三苯基膦钯、过硫酸钠、异丁醇的摩尔比为1: 0.15:4:50的比例,依次将1mmol 4-苯基-1-(对甲苯基)-1H-1,2,3-三唑、0.15mmol四三苯基膦钯、4mmol过硫酸钠、50mmol异丁醇加入到反应器中,在120℃反应18h;(1) According to the molar ratio of 4-phenyl-1-(p-tolyl)-1 H -1,2,3-triazole (1a), tetrakistriphenylphosphine palladium, sodium persulfate, and isobutanol: The ratio of 1:0.15:4:50, followed by 1mmol 4-phenyl-1-(p-tolyl)-1H-1,2,3-triazole, 0.15mmol tetrakistriphenylphosphine palladium, 4mmol persulfuric acid Sodium and 50mmol isobutanol were added to the reactor, and the reaction was carried out at 120°C for 18h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯120mL萃取反应产物5次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:2)为淋洗液进行柱层析(400目硅胶)提纯即得235mg产品4-(2-异丙氧基苯基)-1-(对甲苯基)-1H-1,2,3-三唑2i,收率为80%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted with 120 mL of ethyl acetate for 5 times. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:2) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 235 mg of product 4-(2-isopropoxyphenyl)-1-(p-tolyl) -1H -1,2,3-triazole 2i, the yield is 80%, and the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.49 (s, 1H), 8.41(dd, J = 7.7, 1.5 Hz, 1H), 7.65 (d, J = 8.3 Hz, 2H), 7.35 – 7.30 (m, 3H),7.09 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 3.91 (d, J = 6.4 Hz, 2H),2.43 (s, 3H), 2.27 – 2.21 (m, 1H), 1.12 (d, J = 6.7 Hz, 6H). 13C NMR (150 MHz,CDCl3) δ = 155.2, 143.8, 138.5, 135.0, 130.2, 129.0, 127.8, 120.9, 120.8,120.2, 119.0, 111.5, 74.8, 28.4, 21.1, 19.6。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.49 (s, 1H), 8.41 (dd, J = 7.7, 1.5 Hz, 1H), 7.65 (d, J = 8.3 Hz, 2H), 7.35 – 7.30 (m, 3H), 7.09 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 3.91 (d, J = 6.4 Hz, 2H), 2.43 ( s, 3H), 2.27 – 2.21 (m, 1H), 1.12 (d, J = 6.7 Hz, 6H). 13 C NMR (150 MHz, CDCl 3 ) δ = 155.2, 143.8, 138.5, 135.0, 130.2, 129.0, 127.8, 120.9, 120.8, 120.2, 119.0, 111.5, 74.8, 28.4, 21.1, 19.6.

实施例10:4-(2-(环己氧基)苯基)-1-(对甲苯基)-1H-1,2,3-三唑(2j)合成,具体包括以下步骤:Example 10: Synthesis of 4-(2-(cyclohexyloxy)phenyl)-1-(p-tolyl)-1H- 1,2,3 -triazole (2j), which specifically includes the following steps:

(1)按4-苯基-1-(对甲苯基)-1H-1,2,3-三唑(1a)、氯化钯、过硫酸钾、环己醇的摩尔比为1: 0.10:5:60的比例,依次将1mmol 4-苯基-1-(对甲苯基)-1H-1,2,3-三唑、0.10mmol氯化钯、5mmol过硫酸钾、60mmol环己醇加入到反应器中,在130℃反应20h;(1) The molar ratio of 4-phenyl-1-(p-tolyl)-1H- 1,2,3 -triazole (1a), palladium chloride, potassium persulfate and cyclohexanol is 1:0.10 : 5:60 ratio, followed by 1mmol 4-phenyl-1-(p-tolyl)-1H-1,2,3-triazole, 0.10mmol palladium chloride, 5mmol potassium persulfate, 60mmol cyclohexanol added to the reactor and reacted at 130°C for 20h;

(2)所得反应产物用40mL水稀释,再用乙酸乙酯120mL萃取反应产物5次,收集合并萃取液,水洗涤干燥后,减压蒸馏去溶剂得粗产品,再以乙酸乙酯-石油醚混合液(体积比1:3)为淋洗液进行柱层析(400目硅胶)提纯即得260mg产品4-(2-(环己氧基)苯基)-1-(对甲苯基)-1H-1,2,3-三唑2j,收率为78%,反应方程式如下:(2) The obtained reaction product was diluted with 40 mL of water, and the reaction product was extracted with 120 mL of ethyl acetate for 5 times. The combined extracts were collected, washed with water and dried, and the solvent was distilled off under reduced pressure to obtain a crude product, which was then mixed with ethyl acetate-petroleum ether. The mixed solution (volume ratio 1:3) was used as the eluent and purified by column chromatography (400 mesh silica gel) to obtain 260 mg of product 4-(2-(cyclohexyloxy)phenyl)-1-(p-tolyl)- 1 H -1,2,3-triazole 2j, the yield is 78%, the reaction equation is as follows:

产物核磁共振谱表征数据如下:1H NMR (600 MHz, CDCl3) δ = 8.50 (s, 1H), 8.41(dd, J = 7.7, 1.7 Hz, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.1 Hz,2H), 7.31 – 7.28 (m, 1H), 7.09 – 7.05 (m, 1H), 7.01 (d, J = 8.3 Hz, 1H), 4.48– 4.42 (m, 1H), 2.44 (s, 3H), 2.13 (dd, J = 12.9, 3.7 Hz, 2H), 1.84 – 1.80(m, 2H), 1.64 – 1.59 (m, 4H), 1.44 (tdd, J = 10.5, 7.1, 3.5 Hz, 2H). 13C NMR(150 MHz, CDCl3) δ = 153.9, 143.9, 138.5, 135.1, 130.2, 128.8, 128.0, 120.9,120.7, 120.3, 119.9, 113.0, 75.9, 32.1, 25.5, 23.9, 21.1。The NMR spectral characterization data of the product are as follows: 1 H NMR (600 MHz, CDCl 3 ) δ = 8.50 (s, 1H), 8.41 (dd, J = 7.7, 1.7 Hz, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 7.31 – 7.28 (m, 1H), 7.09 – 7.05 (m, 1H), 7.01 (d, J = 8.3 Hz, 1H), 4.48 – 4.42 (m , 1H), 2.44 (s, 3H), 2.13 (dd, J = 12.9, 3.7 Hz, 2H), 1.84 – 1.80(m, 2H), 1.64 – 1.59 (m, 4H), 1.44 (tdd, J = 10.5 , 7.1, 3.5 Hz, 2H). 13 C NMR (150 MHz, CDCl 3 ) δ = 153.9, 143.9, 138.5, 135.1, 130.2, 128.8, 128.0, 120.9,120.7, 120.3, 119.9, 111.0, 5.5.9, , 23.9, 21.1.

实施例11:致病菌的活化Example 11: Activation of pathogenic bacteria

(1)马铃薯葡萄糖琼脂培养基(PDA):马铃薯200g、葡萄糖20g、琼脂20g、蒸馏水1000mL;(1) Potato dextrose agar medium (PDA): 200 g of potato, 20 g of glucose, 20 g of agar, and 1000 mL of distilled water;

(2)将分离自三七根部的致病菌进行纯化鉴定,鉴定为尖孢镰刀菌(Fusarium oxysporum)、腐皮镰刀菌(Fusarium solani)和毁坏柱孢霉(Cylindrocarpon destructans),将上述菌种接种在PDA培养基上进行活化,接种3~4次后,取生长旺盛的菌株备用。(2) Purify and identify the pathogenic bacteria isolated from the roots of Panax notoginseng, and identify them as Fusarium oxysporum , Fusarium solani and Cylindrocarpon destructans . Inoculate on PDA medium for activation, after inoculation 3 to 4 times, take the vigorously growing strains for use.

实施例12:化合物最低抑菌浓度(MIC)测定Example 12: Compound Minimum Inhibitory Concentration (MIC) Determination

(1)将实施例所合成的化合物2a、2b、2c、2d、2e、2f、2j分别用DMSO溶解、配制成6mg/mL的水溶液;(1) Compounds 2a, 2b, 2c, 2d, 2e, 2f, and 2j synthesized in the examples were dissolved in DMSO and prepared into an aqueous solution of 6 mg/mL;

(2)取实施例11中生长7d的病原菌,用20mL 1/4 PDA液体培养基(不添加琼脂,马铃薯和葡萄糖的量为常规培养基的1/4)冲洗培养基,然后制成孢子浓度为 1×104个/mL的孢子悬浮液;(2) Take the pathogenic bacteria grown for 7 days in Example 11, wash the medium with 20mL 1/4 PDA liquid medium (without adding agar, the amount of potato and glucose is 1/4 of the conventional medium), and then prepare the spore concentration It is a spore suspension of 1×10 4 /mL;

(3)在96孔板中加入0.22μm微孔滤膜过滤除菌的4μL单体化合物和156μL步骤(2)中制成的孢子悬浮液;用二倍稀释法配置浓度范围为150μg/mL-0.146μg/mL的多个浓度梯度液体;(3) Add 4 μL of the monomer compound and 156 μL of the spore suspension prepared in step (2) into a 96-well plate; the concentration range is 150 μg/mL- Multiple concentration gradient liquids of 0.146μg/mL;

(4)空白对照是4μL DMSO以及156μL1/4PDA液体培养基;阳性对照为4μL DMSO和150μL步骤(3)中的孢子悬浮液;(4) The blank control is 4 μL DMSO and 156 μL 1/4PDA liquid medium; the positive control is 4 μL DMSO and 150 μL spore suspension in step (3);

(5)96孔板28℃恒温培养36h,然后检查孔内真菌生长情况;在595nm处用酶标仪(Thermo 1510)测量每个孔的吸光度,结果见下表;(5) The 96-well plate was incubated at a constant temperature of 28°C for 36 hours, and then the fungal growth in the wells was checked; the absorbance of each well was measured with a microplate reader (Thermo 1510) at 595 nm, and the results are shown in the following table;

化合物2a,2b,2d,2f对导致三七根腐病的三个致病菌株都有较强的广谱抑菌活性,与阳性药恶霉灵和粉唑醇的抑菌活性处于同一数量级,抑菌活性高于松土精和霜霉威;化合物2c和2e对尖孢镰刀菌和腐皮镰刀菌有较高抑菌活性,化合物2j对毁坏柱孢霉有较好抑菌活性。Compounds 2a, 2b, 2d, and 2f have strong broad-spectrum antibacterial activities against the three pathogenic strains causing Panax notoginseng root rot, which are in the same order of magnitude as the antibacterial activities of the positive drugs oxamidil and fenconazole. The antibacterial activity was higher than that of ripper and propamocarb. Compounds 2c and 2e had higher bacteriostatic activities against Fusarium oxysporum and Fusarium solani, and compound 2j had better antibacterial activity against Cylindrosporium.

Claims (6)

1.结构式如式Ⅰ或式Ⅱ所示的4-邻烷氧芳基-1,2,3-三唑衍生物:1. The 4-o-alkoxyaryl-1,2,3-triazole derivatives represented by the structural formula I or II: , 其中R1选自H、Me、OMe、OH、CH2OH、F、Cl、Br;R2选自H、Me、OMe、F、Cl、Br;R3选自H、Me、OMe、OEt、 n PrO、F、Cl、Br;R4选自Me、Et、 n Pr、 i Pr、Cy。Wherein R 1 is selected from H, Me, OMe, OH, CH 2 OH, F, Cl, Br; R 2 is selected from H, Me, OMe, F, Cl, Br; R 3 is selected from H, Me, OMe, OEt , n PrO, F, Cl, Br; R 4 is selected from Me, Et, n Pr, i Pr, Cy. 2.权利要求1所述的4-邻烷氧芳基-1,2,3-三唑衍生物的合成方法,其特征在于:按1,4-二取代-1,2,3-三氮唑、催化剂、氧化剂、溶剂的摩尔比为1:(0.01~0.3):(2~7):(20~80)的比例,依次将1,4-二取代-1,2,3-三氮唑、催化剂、氧化剂、溶剂加入到反应器中,在70℃~150℃下反应6~24h;反应产物水稀释后用乙酸乙酯多次萃取,收集合并萃取液,经洗涤、干燥、减压蒸馏得粗产品,再分离提纯,即得4-邻烷氧芳基-1,2,3-三唑衍生物。2. the synthetic method of 4-o-alkoxyaryl-1,2,3-triazole derivatives according to claim 1, is characterized in that: by 1,4-disubstituted-1,2,3-triazol The molar ratio of azole, catalyst, oxidant and solvent is 1:(0.01~0.3):(2~7):(20~80), and 1,4-disubstituted-1,2,3-triazine The azole, catalyst, oxidant, and solvent were added to the reactor, and the reaction was carried out at 70°C to 150°C for 6 to 24 hours; the reaction product was diluted with water and then extracted with ethyl acetate for several times. The combined extracts were collected, washed, dried, and decompressed. The crude product is obtained by distillation, and then separated and purified to obtain 4-o-alkoxyaryl-1,2,3-triazole derivatives. 3.根据权利要求2所述的4-邻烷氧芳基-1,2,3-三唑衍生物的合成方法,其特征在于:催化剂为醋酸钯、二氯化钯、三(二亚苄基丙酮)二钯、双二亚苄基丙酮钯、四三苯基膦钯中的一种。3. the synthetic method of 4-o-alkoxyaryl-1,2,3-triazole derivatives according to claim 2, is characterized in that: catalyzer is palladium acetate, palladium dichloride, tris(dibenzylidene) acetone) dipalladium, bisdibenzylideneacetone palladium, tetrakistriphenylphosphine palladium. 4.根据权利要求2所述的4-邻烷氧芳基-1,2,3-三唑衍生物的合成方法,其特征在于:氧化剂为过硫酸钾、过硫酸铵、过硫酸钠、过硫酸氢钾、过氧化二叔丁醇中的一种。4. the synthetic method of 4-o-alkoxyaryl-1,2,3-triazole derivatives according to claim 2, is characterized in that: oxidant is potassium persulfate, ammonium persulfate, sodium persulfate, persulfate One of potassium hydrogen sulfate and di-tert-butanol peroxide. 5.根据权利要求2所述的4-邻烷氧芳基-1,2,3-三唑衍生物的合成方法,其特征在于:溶剂为甲醇、乙醇、正丙醇、异丁醇、环己醇溶剂中的一种。5. the synthetic method of 4-o-alkoxy aryl-1,2,3-triazole derivatives according to claim 2, it is characterized in that: solvent is methanol, ethanol, n-propanol, isobutanol, ring One of the hexanol solvents. 6.权利要求1所述的4-邻烷氧芳基-1,2,3-三唑衍生物在抑制三七根腐病致病菌中的应用。6. The application of the 4-o-alkoxyaryl-1,2,3-triazole derivative of claim 1 in inhibiting the pathogenic bacteria of Panax notoginseng root rot.
CN201910661275.2A 2019-07-22 2019-07-22 4-o-alkoxy aryl-1, 2, 3-triazole derivative, and synthesis method and application thereof Active CN110396068B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910661275.2A CN110396068B (en) 2019-07-22 2019-07-22 4-o-alkoxy aryl-1, 2, 3-triazole derivative, and synthesis method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910661275.2A CN110396068B (en) 2019-07-22 2019-07-22 4-o-alkoxy aryl-1, 2, 3-triazole derivative, and synthesis method and application thereof

Publications (2)

Publication Number Publication Date
CN110396068A true CN110396068A (en) 2019-11-01
CN110396068B CN110396068B (en) 2023-01-20

Family

ID=68324916

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910661275.2A Active CN110396068B (en) 2019-07-22 2019-07-22 4-o-alkoxy aryl-1, 2, 3-triazole derivative, and synthesis method and application thereof

Country Status (1)

Country Link
CN (1) CN110396068B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592321A (en) * 2021-01-15 2021-04-02 贵州大学 1, 2, 3-triazole hydrazide or amide compounds and preparation method and application thereof
CN115403533A (en) * 2021-05-28 2022-11-29 永康市第一人民医院 1-styryl-1, 2, 3-triazole compound and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN88101622A (en) * 1987-03-21 1988-10-05 先灵农业化学品公司 Fungicidal agents
CN103275022A (en) * 2013-06-08 2013-09-04 浙江工业大学 1-benzyl-1, 2, 3-triazole compound, as well as preparation method and application thereof
CN106117154A (en) * 2016-06-30 2016-11-16 昆明理工大学 A kind of adjacent aryloxy group 1,4 diaryl 1,2,3 triazole derivatives and its preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN88101622A (en) * 1987-03-21 1988-10-05 先灵农业化学品公司 Fungicidal agents
CN103275022A (en) * 2013-06-08 2013-09-04 浙江工业大学 1-benzyl-1, 2, 3-triazole compound, as well as preparation method and application thereof
CN106117154A (en) * 2016-06-30 2016-11-16 昆明理工大学 A kind of adjacent aryloxy group 1,4 diaryl 1,2,3 triazole derivatives and its preparation method and application

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AITZIBER IRASTORZA ET AL.: "Triazole-Directed Pd-Catalyzed C(sp2 )−H Oxygenation of Arenes and Alkenes", 《ORGANIC LETTERS》 *
GATTU SRIDHAR ET AL.: "ZrCl4 Mediated synthesis of 1,2,3-triazoles from vinyl nitrates and their biological evaluation", 《SYNTHETIC COMMUNICATIONS》 *
MA ANGELES BONACHE ET AL.: "Small Library of Triazolyl Polyphenols Correlating Antioxidant Activity and Stability with Number and Position of Hydroxyl Groups", 《ACS COMBINATORIAL SCIENCE》 *
MOHAMMAD SAYED ALAM ET AL.: "Structure-Antimicrobial Activity Relationship of 4- or 5-Substituted 1-(2,6-Dichloro-4-trifluoromethylphenyl)-1H-1,2,3-triazole Analogues", 《J. KOREAN SOC. APPL. BIOL. CHEM.》 *
SUPING SHI ET AL.: "Palladium-Catalyzed Ortho-Alkoxylation of 2‑Aryl-1,2,3-triazoles", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *
YONGSHENG REN ET AL.: "Palladium-catalyzed selective ortho CeH alkoxylation at 4-aryl of 1, 4- disubstituted 1, 2, 3-triazoles", 《TETRAHEDRON》 *
YUAN-YUAN ZHU ET AL.: "Intramolecular Six-Membered and Three-Center C-H 333 O Hydrogen Bonding in 1,4-Diphenyl-1,2,3-Triazoles", 《CRYSTAL GROWTH & DESIGN》 *
张辉等: "1,2,3-三唑类化合物的合成及其体外抗肿瘤活性", 《上海医药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592321A (en) * 2021-01-15 2021-04-02 贵州大学 1, 2, 3-triazole hydrazide or amide compounds and preparation method and application thereof
CN115403533A (en) * 2021-05-28 2022-11-29 永康市第一人民医院 1-styryl-1, 2, 3-triazole compound and preparation method and application thereof
CN115403533B (en) * 2021-05-28 2023-08-25 永康市第一人民医院 1-styryl-1, 2, 3-triazole compound as well as preparation method and application thereof

Also Published As

Publication number Publication date
CN110396068B (en) 2023-01-20

Similar Documents

Publication Publication Date Title
CN111420709B (en) Application of Azacyclic Carbene-type Mixed Nickel(II) Complexes in the Synthesis of 2-Linear Alkyl Benzothiazoles
CN110396068B (en) 4-o-alkoxy aryl-1, 2, 3-triazole derivative, and synthesis method and application thereof
CN106588788B (en) One-pot two-step method for synthesizing 1,2,3-triazoles
CN108033922A (en) A kind of preparation method of 3- acyl groups quinokysalines derivative
CA2658773C (en) Asymmetric hydrogenation of 1,1,1-trifluoroacetone
US4960911A (en) Process for the preparation of oxiranes
Ren et al. Palladium-catalyzed selective ortho C–H alkoxylation at 4-aryl of 1, 4-disubstituted 1, 2, 3-triazoles
CN101235023B (en) A kind of synthetic method of spirodiclofen
CN101602656A (en) A kind of synthetic method of hinokitiol
CN104945339B (en) A kind of preparation method of 1,4 2 substitution, 1,2,3 triazole derivatives
CN109776407B (en) Preparation method of 2-methyl-4-hydroxymethyl quinoline and derivatives thereof
CN108794412A (en) A kind of preparation method of 4,5- diaryl -2H-1,2,3- triazole compounds
CN115819251B (en) Preparation method of (1R) -1- [3- (difluoromethyl) -2-fluorophenyl ] ethylamine
CN108794541B (en) A kind of ruthenium carbonyl complex containing pyridinemethanol and its application
CN111704584A (en) Benzotriazole and derivative high-selectivity N2 alkylation method thereof
CN110423239B (en) 1, 3-oxazine 1,2, 3-triazole derivative and synthetic method and application thereof
CN102040581A (en) Preparation method of 2-amino-3-cyan-4-aryl-4H-benzopyranyl
CN104910095B (en) The preparation method of 4-replacement-thiazolamine compound
CN113185478B (en) Preparation method of N-tert-butyloxycarbonyl piperazine
CN1760187A (en) Method for preparing Tebucomazole in high purity
CN101250173A (en) A kind of preparation method of spiromethimen
CN101412667B (en) Preparation of 2-pimelie kelone compound
CN109734667A (en) A kind of polysubstituted imidazole compound and its synthetic method and application
CN109912521B (en) Method for synthesizing alkenyl-substituted 1,2, 3-triazole derivative in one step
Nilsson et al. Enamine synthesis from functionalized carbonyl compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant